Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, B-Blockers and Combination Antihypertensive Drug Regimes in Iraq
Hypertension is a major health problem throughout the world because of its high prevalence and its association with increased risk of cardiovascular diseases. It is defined as systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg. The aim of this study was to compare the...
Main Authors: | Dlveen M. Sulaiman, Kassim J.Al-Shamma, Ansam N.Al-Hassani |
---|---|
Format: | Article |
Language: | English |
Published: |
College of Pharmacy University of Baghdad
2017-03-01
|
Series: | Iraqi Journal of Pharmaceutical Sciences |
Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/418 |
Similar Items
-
COMBINED ANTIHYPERTENSIVE THERAPY: ACE INHIBITOR PLUS CALCIUM CHANNEL BLOCKER. NEW ADVANTAGES OF THE KNOWN COMBINATION
by: S. A. Boitsov, et al.
Published: (2016-01-01) -
Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01) -
Place of angiotensin receptor blockers in antihypertensive therapy
by: A I Martynov, et al.
Published: (2014-03-01) -
Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01) -
Serum status of selenium and chromium in patients with cardiovascular diseases and controls in Iraq.
by: Kassim M. Al Doori
Published: (2009-01-01)